Large Outflow of Money Witnessed in DexCom

DexCom (DXCM) : The value of composite uptick trades was $9.19 million, whereas, the value of composite downtick trades was $18.59 million. The uptick to downtick ratio stood at 0.49 with a negative money flow of ($9.4) Million during Tuesdays trading session. The block trades money flow was negative ($9.94 million). The transaction of the trades on downticks amounted to $9.94 million, which confirms investors selling on the strength of price. DexCom (DXCM) gained 53 cents at $79.4, an increase of 0.67% over the previous days close.


The company Insiders own 2.8% of DexCom shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -6.76% . Institutional Investors own 94.04% of DexCom shares. During last six month period, the net percent change held by insiders has seen a change of -10.1%. In an insider trading activity, The Securities and Exchange Commission has divulged that Moy Jeffrey, Officer (Svp, Operations) of DEXCOM INC, had unloaded 4,557 shares at an average price of $80 in a transaction dated on June 29, 2016. The total value of the transaction was worth $364,560.

Shares of DexCom, Inc. rose by 0.95% in the last five trading days and 10.97% for the last 4 weeks. DexCom, Inc. is up 22.22% in the last 3-month period. Year-to-Date the stock performance stands at -2.56%.

DexCom (NASDAQ:DXCM): stock turned positive on Tuesday. Though the stock opened at $79.9, the bulls momentum made the stock top out at $81 level for the day. The stock recorded a low of $79.4 and closed the trading day at $79.8, in the green by 0.50%. The total traded volume for the day was 622,946. The stock had closed at $79.4 in the previous days trading.

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.